Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice.

Source:http://linkedlifedata.com/resource/pubmed/id/17591805

Download in:

View as

General Info

PMID
17591805